Investor's Business Daily on MSN3h
Is Moderna Stock A Sell As RFK Jr. Reportedly Mulls A Massive Funding Pull?
Moderna stock is under pressure, again, as Robert F. Kennedy Jr. reportedly mulls pulling the company's federal funding to ...
The Columbian4h
MRNA vaccines, once a Trump boast, now face attacks from some in GOP
Researchers racing to develop bird flu vaccines for humans have turned to a cutting-edge technology that enabled the rapid development of lifesaving covid shots.
STAT7h
In the Boston area, biotech’s hub, a slump is being acutely felt
In the Boston area, three months into the new year, the mood in the biotech industry has soured and the outlook has clouded.
‘The hangover can last longer than the party’: Biotech is in a major slump, with no end in sight
There are few signs the industry responsible for more than 115,000 Massachusetts jobs is pulling out of its four-year downswing.
Moderna initiated with a Neutral at Citi
Citi initiated coverage of Moderna (MRNA) with a Neutral rating and $40 price target Healthcare policy remains a key biopharma sector ...
WFAE 90.718h
NIH cuts off more research funding, including for vaccine hesitancy. mRNA may be next
The National Institutes of Health is terminating dozens of studies examining why people are hesitant about vaccines and how ...
South Carolina Public Radio21h
NIH cuts funding for vaccine hesitancy research and may target mRNA research too
The National Institutes of Health is terminating dozens of studies examining why people are hesitant about vaccines and how ...